Protalix BioTherapeutics (PLX) Institutional Ownership

$1.14
-0.03 (-2.56%)
(As of 05/17/2024 ET)

Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)

Current
Institutional Ownership
Percentage
16.53%
Number of
Institutional Buyers
(last 12 months)
11
Total
Institutional Inflows
(last 12 months)
$121.22K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$107.99K
Get PLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PLX Institutional Buying and Selling by Quarter

Protalix BioTherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029%
5/3/2024 GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673%
2/2/2024 Bailard Inc.68,100$121K0.0%N/A0.095%
1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132%
11/15/2023 GSA Capital Partners LLP496,781$825K0.1%N/A0.694%
11/13/2023 Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234%
11/7/2023 Barclays PLC46,511$77K0.0%+251.6%0.065%
10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193%
10/24/2023 Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231%
10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042%
9/21/2023 Barclays PLC13,230$26K0.0%+561.5%0.018%
8/11/2023 Natixis132,000$264K0.0%N/A0.202%
8/4/2023 American International Group Inc.27,034$54K0.0%N/A0.041%
7/31/2023 Orin Green Financial LLC60,150$120K0.1%N/A0.092%
7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168%
5/10/2023 Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243%
5/9/2023 Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024%
2/7/2023Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101%
7/26/2022 Capital Performance Advisors LLP25,974$28K0.0%N/A0.055%
5/9/2022 Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527%
4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321%
1/31/2022Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088%
1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276%
11/15/2021 GSA Capital Partners LLP254,871$339K0.0%N/A0.559%
11/12/2021 Credit Suisse AG31,974$43K0.0%-51.5%0.070%
8/18/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538%
8/17/2021 Walleye Capital LLC346,539$662K0.0%N/A0.764%
8/17/2021 Walleye Trading LLC135,000$258K0.0%N/A0.297%
8/17/2021 Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868%
8/16/2021 Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102%
8/16/2021 Credit Suisse AG65,925$126K0.0%+559.3%0.145%
8/13/2021 Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066%
8/12/2021 XTX Topco Ltd17,148$33K0.0%N/A0.038%
8/11/2021Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146%
8/5/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538%
5/19/2021Virtu Financial LLC27,744$124K0.0%N/A0.061%
5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821%
5/17/2021 Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197%
5/17/2021 DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655%
5/14/2021 Laurion Capital Management LP42,813$191K0.0%N/A0.094%
The Overlooked Retirement Asset You Probably Don’t Own (Ad)

4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.

Click here to access the Crypto Retirement Blueprint now.
5/14/2021 Credit Suisse AG10,000$45K0.0%N/A0.022%
5/13/2021 Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119%
5/10/2021 Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538%
5/7/2021 D.A. Davidson & CO.130,700$583K0.0%N/A0.288%
4/30/2021 Ground Swell Capital LLC14,684$65K0.2%N/A0.032%
4/28/2021 DAVENPORT & Co LLC12,000$54K0.0%N/A0.026%
2/17/2021 Jane Street Group LLC22,218$81K0.0%+51.5%0.067%
2/16/2021 Squarepoint Ops LLC22,068$80K0.0%-50.6%0.066%
2/4/2021 GSA Capital Partners LLP10,042$36K0.0%N/A0.030%
11/17/2020 Jane Street Group LLC14,661$57K0.0%-89.8%0.044%
11/16/2020 Squarepoint Ops LLC44,679$173K0.0%N/A0.134%
11/12/2020 Arrowstreet Capital Limited Partnership45,853$177K0.0%+32.3%0.138%
11/10/2020 Phoenix Holdings Ltd.204,355$751K0.0%+8.5%0.613%
8/31/2020 Bridgeway Capital Management Inc.174,291$661K0.0%+94.8%0.537%
8/17/2020 Jane Street Group LLC143,821$542K0.0%+185.6%0.443%
8/12/2020 Bank of Montreal Can173,704$615K0.0%N/A0.535%
8/10/2020 Phoenix Holdings Ltd.188,336$681K0.0%N/A0.581%
7/29/2020Psagot Investment House Ltd.470,255$1.73M0.0%+15.7%1.450%
5/15/2020 Jane Street Group LLC50,352$124K0.0%+53.4%0.339%
(Data available from 1/1/2016 forward)

PLX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PLX shares?

During the previous two years, 14 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were GSA Capital Partners LLP ($622K), Connor Clark & Lunn Investment Management Ltd. ($278K), Bank of New York Mellon Corp ($275K), Natixis ($264K), Allspring Global Investments Holdings LLC ($229K), Denali Advisors LLC ($169K), and Bailard Inc. ($121K).Learn more on PLX's institutional investors.

What percentage of Protalix BioTherapeutics stock is owned by institutional investors?

16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings.

Which institutional investors have been buying Protalix BioTherapeutics stock?

Of the 14 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: GSA Capital Partners LLP ($496.78K), Connor Clark & Lunn Investment Management Ltd. ($210.70K), Allspring Global Investments Holdings LLC ($137.91K), Natixis ($132K), Denali Advisors LLC ($110.20K), Bailard Inc. ($68.10K), and Orin Green Financial LLC ($60.15K).

How much institutional buying is happening at Protalix BioTherapeutics?

Institutional investors have bought a total of 1,428,234 shares in the last 24 months. This purchase volume represents approximately $613.38K in transactions.

Which Protalix BioTherapeutics major shareholders have been selling company stock?

The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: GSA Capital Partners LLP ($50.67K), Denali Advisors LLC ($15.50K), and SG Americas Securities LLC ($13.14K).

How much institutional selling is happening at Protalix BioTherapeutics?

Institutional investors have sold a total of 79,306 shares in the last 24 months. This volume of shares sold represents approximately $107.99K in transactions.


This page (NYSE:PLX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners